+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Insemination - Global Market Trajectory & Analytics

  • ID: 5139632
  • Report
  • April 2021
  • Region: Global
  • 131 Pages
  • Global Industry Analysts, Inc
Global Artificial Insemination Market to Reach $2.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Artificial Insemination estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027. Intrauterine Insemination, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$1.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Intravaginal Insemination segment is readjusted to a revised 6.4% CAGR for the next 7-year period.



The U.S. Market is Estimated at $468.1 Million, While China is Forecast to Grow at 6.2% CAGR

The Artificial Insemination market in the U.S. is estimated at US$468.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$434.3 Million by the year 2027 trailing a CAGR of 6.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Intratubal Insemination Segment to Record 6.1% CAGR

In the global Intratubal Insemination segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$60.7 Million in the year 2020 will reach a projected size of US$92.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$285.3 Million by the year 2027.

Select Competitors (Total 41 Featured):
  • Genea Limited
  • Hi-Tech Solutions
  • Irvine Scientific
  • KITAZATO CORPORATION
  • Pride Angel Ltd.
  • Rinovum Women's Health, LLC.
  • Rocket Medical PLC
  • Vitrolife AB
Frequently Asked Questions about the Global Market for Artificial Insemination

What is the estimated value of the Global Market for Artificial Insemination?

The Global Market for Artificial Insemination was estimated to be valued at $1.6 Billion in 2020.

What is the growth rate of the Global Market for Artificial Insemination?

The growth rate of the Global Market for Artificial Insemination is 6.6%, with an estimated value of $2.5 Billion by 2027.

What is the forecasted size of the Global Market for Artificial Insemination?

The Global Market for Artificial Insemination is estimated to be worth $2.5 Billion by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGY
II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Artificial Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Artificial Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Artificial Insemination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Intrauterine Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Intrauterine Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Intrauterine Insemination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Intravaginal Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Intravaginal Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Intravaginal Insemination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Intratubal Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Intratubal Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Intratubal Insemination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS
  • Table 16: USA Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 17: USA Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: USA 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 19: Canada Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: Canada Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: Canada 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 22: Japan Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 23: Japan Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: Japan 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 25: China Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: China Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: China 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 28: Europe Current & Future Analysis for Artificial Insemination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 29: Europe Historic Review for Artificial Insemination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: Europe 15-Year Perspective for Artificial Insemination by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 31: Europe Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Europe Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: Europe 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 34: France Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: France Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: France 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 37: Germany Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Germany Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: Germany 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 40: Italy Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: Italy Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: Italy 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 43: UK Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: UK Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: UK 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 46: Rest of Europe Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Rest of Europe Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Rest of Europe 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 49: Asia-Pacific Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Asia-Pacific Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 51: Asia-Pacific 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027
  • Table 52: Rest of World Current & Future Analysis for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 53: Rest of World Historic Review for Artificial Insemination by Type - Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 54: Rest of World 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine Insemination, Intravaginal Insemination, Intratubal Insemination and Other Types for the Years 2012, 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown